Sale of Clario

Summary by AI BETAClose X

Partners Group Private Equity Ltd has announced the sale of Clario to Thermo Fisher Scientific. As of August 31, 2025, Clario represented approximately EUR 27.5 million of PGPE Ltd's portfolio, making it the eighth-largest investee company. The transaction values PGPE Ltd's stake in Clario in line with the latest published NAV. PGPE Ltd's initial investment in eResearch Technology (ERT) occurred in 2020, followed by participation in a follow-on investment in 2021 to facilitate ERT's merger with BioClinica, which created Clario; the total investment by PGPE Ltd amounted to EUR 13.5 million. The sale is pending customary regulatory approvals and is anticipated to be finalized by the end of Q2 2026.

Disclaimer*

UK 100

Latest directors dealings